Germline and somatic variations influence the somatic mutational signatures of esophageal squamous cell carcinomas in a Chinese population
暂无分享,去创建一个
B. Guleng | Qiyuan Li | Yulin Zhou | Jintao Guo | Yuanyuan Zeng | Ying Zhou | Jiankun Huang | Liying Yu | Huili Li | Lingyun Hou | Liuwei Zhu | Dandan Ge | Yulin Zhou
[1] H. Matsubara,et al. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma , 2017, Oncology.
[2] Jean-François Deleuze,et al. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis , 2017, Nature Communications.
[3] Michael Jones,et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer , 2017, Nature Genetics.
[4] E. Lander,et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer , 2017, Nature Genetics.
[5] C. Lindskog,et al. A pathology atlas of the human cancer transcriptome , 2017, Science.
[6] S. Law,et al. Whole‐exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma , 2017, The Journal of pathology.
[7] H. Matsubara,et al. ZNF750 Expression as a Novel Candidate Biomarker of Chemoradiosensitivity in Esophageal Squamous Cell Carcinoma , 2017, Oncology.
[8] E. Birney,et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures , 2017, Nature Medicine.
[9] P. Gibbard,et al. Anthropocene: keep communication clear , 2017, Nature.
[10] David J. Barry,et al. APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability. , 2017, Cancer discovery.
[11] Benjamin J. Raphael,et al. Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.
[12] D. Lin,et al. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma , 2016, Oncogene.
[13] Xin Xu,et al. Spatial intratumor heterogeneity of genetic, epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma , 2016, Nature Genetics.
[14] X. Hua,et al. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer , 2016, British Journal of Cancer.
[15] Nicola D. Roberts,et al. Germline MC1R status influences somatic mutation burden in melanoma , 2016, Nature Communications.
[16] H. Aburatani,et al. Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. , 2016, Gastroenterology.
[17] Gad Getz,et al. Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors , 2016, Nature Genetics.
[18] B. Taylor,et al. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution , 2016, Genome Biology.
[19] Jiansheng Guo,et al. Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma , 2016, GigaScience.
[20] K. Somasundaram,et al. Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing , 2015, Oncotarget.
[21] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[22] James Y. Dai,et al. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma , 2015, Human Genomics.
[23] Zhen-bo Feng,et al. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[24] M. Stephens,et al. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures , 2015, bioRxiv.
[25] Huanming Yang,et al. Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma , 2015, American journal of human genetics.
[26] Trevor J Pugh,et al. Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.
[27] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[28] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[29] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[30] J. Ferlay,et al. Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.
[31] Jian Sun,et al. Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.
[32] M. Rubin,et al. Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men , 2014, Clinical Cancer Research.
[33] Serena Nik-Zainal,et al. Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.
[34] S. Misra,et al. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. , 2014, World journal of gastrointestinal oncology.
[35] Li Shang,et al. Genomic and molecular characterization of esophageal squamous cell carcinoma , 2014, Nature Genetics.
[36] Qiang Feng,et al. Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.
[37] M. Stratton,et al. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes , 2014, Current opinion in genetics & development.
[38] David E Larson,et al. Using VarScan 2 for Germline Variant Calling and Somatic Mutation Detection , 2013, Current protocols in bioinformatics.
[39] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[40] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[41] Iuliana Ionita-Laza,et al. Sequence kernel association tests for the combined effect of rare and common variants. , 2013, American journal of human genetics.
[42] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[43] M. Stratton,et al. Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.
[44] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[45] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[46] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[47] M. Lai,et al. Identification of distinct gene expression profiles between esophageal squamous cell carcinoma and adjacent normal epithelial tissues. , 2012, The Tohoku journal of experimental medicine.
[48] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[49] Dana Pe'er,et al. JISTIC: Identification of Significant Targets in Cancer , 2010, BMC Bioinformatics.
[50] Liyu Cao,et al. Expression and clinical significance of S100A2 and p63 in esophageal carcinoma. , 2009, World journal of gastroenterology.
[51] N. Hu,et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China , 2009, BMC Cancer.
[52] M. Stratton,et al. The cancer genome , 2009, Nature.
[53] Cai,et al. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. , 2016 .
[54] F. Kim,et al. The Cancer , 2015, International braz j urol : official journal of the Brazilian Society of Urology.
[55] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[56] Trevor J Pugh,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[57] Claude-Alain H. Roten,et al. Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..